ADVERTISEMENT

COLORADO ROCKIES

As Rockies get Feltner back, they lose another pitcher to injury

Recent Rockies call-up Welinton Herrera, who did well in three recent appearances, landed on the 15-day injured list.

Watch: What if the Broncos Fall Short Again Like the Avs Did? | Orange and Blue Today | 28 mins

The Rockies’ battered pitching corps can’t seem to catch a break.

On the day Ryan Feltner returned to the rotation to make his first start since April 23 after dealing with right-ulnar-nerve inflammation, the corresponding move ended up involving yet another injury to a pitcher, this one involving recent call-up Welinton Herrera, who heads for the 15-day injured list due to left-elbow inflammation.

Herrera’s injury comes two days after the Rockies transferred starter José Quintana to the 60-day injured list due to an elbow sprain that will not require surgery.

ADVERTISEMENT

In his first three career major-league appearances after being promoted from AAA Albuquerque on May 25, Herrera had allowed two hits and a walk over 2 1/3 innings.

He made his major-league debut last Monday night in Los Angeles, pitching a full inning that night and again one night later. In his first Coors Field appearance on Friday night, he allowed a single and a walk over one-third of an inning before being relieved.

Herrera is the third Rockies reliever on the 40-man roster currently on the injured list, joining Jimmy Herget and Victor Vodnik.

Starter Chase Dollander is also on the 15-day injured list, with starters Quintana and McCade Brown and reliever Pierson Ohl on the 60-day injured list. Ohl underwent Tommy John surgery earlier this year; Brown is in his throwing program as he works his way back from a right-shoulder issue.

Andrew Mason Senior Broncos Writer

Andrew Mason is the Senior Broncos Writer for denversports.com. Mase is in his 28th season covering the NFL and his 23rd on the Broncos beat. In addition to 12 seasons working with the Broncos and two working with the Carolina Panthers, Mase has also… Read more

Comments

0 Comments